Small lymphocytic lymphoma, or SLL, is a slow-growing B-cell non-Hodgkin lymphoma closely related to chronic lymphocytic leukemia (CLL). The key difference is where the abnormal lymphocytes are found: SLL is defined mainly by involvement of lymph nodes or lymphoid tissue, whereas CLL involves the blood and bone marrow more prominently. The biology is closely connected, which is why the two conditions are often discussed together. ^[1][2][3]

Overview

SLL usually follows an indolent course, meaning it can remain stable for long periods. Some patients are diagnosed because of enlarged lymph nodes found on examination or imaging, while others present with fatigue, night sweats, weight loss, recurrent infections, or abnormal blood counts. In many cases, management begins with careful observation rather than immediate treatment. ^[1][2]

Symptoms

Possible symptoms include painless swollen lymph nodes, fatigue, recurrent infections, fever, drenching night sweats, unexplained weight loss, and sometimes abdominal fullness if the spleen enlarges. Some patients have no symptoms at diagnosis. ^[1][2][3]

Causes and risk factors

The exact cause is not usually traceable to one behavior or exposure. Risk increases with age, and the disease reflects acquired changes in lymphocytes rather than something a patient directly “caused.” Some biologic and genetic markers influence prognosis and treatment planning. ^[1][2]

Diagnosis

Diagnosis may involve physical examination, blood tests, imaging, lymph node biopsy, bone marrow evaluation in selected cases, and specialized immunophenotyping or molecular studies. These tests help distinguish SLL from other lymphomas and guide prognosis. ^[1][2][3]

Treatment options

Not every patient needs treatment at diagnosis. Watchful waiting may be appropriate when the disease is stable and symptoms are absent. Treatment is generally considered for progressive symptoms, problematic lymph node enlargement, cytopenias, organ involvement, or other evidence of clinically significant progression. Options may include targeted therapies, monoclonal antibodies, chemoimmunotherapy in selected cases, and supportive care. ^[1][2][3]

Complications and follow-up

Potential complications include infections, low blood counts, autoimmune complications, progressive lymph node disease, and in a minority of patients transformation to a more aggressive lymphoma. Regular follow-up helps detect change before major complications develop. ^[1][2]

When should a doctor be consulted?

Persistent enlarged lymph nodes, unexplained fatigue, night sweats, recurrent infections, or abnormal blood tests warrant medical review. For patients already diagnosed with SLL, rapid change in symptoms or node size should be reported promptly. ^[1][2]

Living with the condition and monitoring

Patients often need help understanding why “no immediate treatment” can still be an active medical strategy. Monitoring may include examination, blood counts, imaging when indicated, infection prevention, and assessment of symptom change. ^[1][2]

Prognosis and follow-up

SLL often progresses slowly, but prognosis varies according to clinical stage, biologic markers, response to therapy, and overall health. Some people live for many years with careful monitoring and modern treatment when needed. ^[1][2][3]

FAQ

Are SLL and CLL the same disease?

They are closely related manifestations of the same disease spectrum, differing mainly in the distribution of abnormal cells. ^[1][2]

Is SLL slow-growing?

Yes, it is often indolent, although the pace can vary from one patient to another. ^[1][2]

Does treatment have to start immediately after diagnosis?

No. Many patients are monitored initially and treated only when the disease becomes clinically active. ^[1][2][3]

What is the most common symptom?

Painless enlarged lymph nodes are a common presentation, but some patients are asymptomatic. ^[1][2]

What is monitored during follow-up?

Symptoms, lymph node size, blood counts, infection risk, and evidence of disease progression are commonly monitored. ^[1][2]